Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR

Satyanarayana R. Pondugula, Patrick C. Flannery, Kodye L. Abbott, Elaine S. Coleman, Sridhar Mani, Temesgen Samuel, Wen Xie

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Activation of human pregnane X receptor (hPXR)-regulated expression of cytochrome P450 3A4 (CYP3A4) and multidrug resistance protein 1 (MDR1) plays an important role in mediating adverse drug interactions. Given the common use of natural products as part of adjunct human health behavior, there is a growing concern about natural products for their potential to induce undesired drug interactions through the activation of hPXR-regulated CYP3A4 and MDR1. Here, we studied whether 3,3'-diindolylmethane (DIM), a natural health supplement, could induce hPXR-mediated regulation of CYP3A4 and MDR1 in human hepatocytes and intestinal cells. DIM, at its physiologically relevant concentrations, not only induced hPXR transactivation of CYP3A4 promoter activity but also induced gene expression of CYP3A4 and MDR1. DIM decreased intracellular accumulation of MDR1 substrate rhodamine 123, suggesting that DIM induces the functional expression of MDR1. Pharmacologic inhibition or genetic knockdown of hPXR resulted in attenuation of DIM induced CYP3A4 and MDR1 gene expression, suggesting that DIM induces CYP3A4 and MDR1 in an hPXR-dependent manner. Together, these results support our conclusion that DIM induces hPXR-regulated CYP3A4 and MDR1 gene expression. The inductive effects of DIM on CYP3A4 and MDR1 expression caution the use of DIM in conjunction with other medications metabolized and transported via CYP3A4 and MDR1, respectively.

Original languageEnglish (US)
Pages (from-to)580-589
Number of pages10
JournalToxicology Letters
Volume232
Issue number3
DOIs
StatePublished - Feb 3 2015

Fingerprint

Cytochrome P-450 CYP3A
P-Glycoprotein
Gene expression
Gene Expression
Drug interactions
Biological Products
Drug Interactions
diindolylmethane
Chemical activation
Health
Rhodamine 123
Health Behavior
Medical Genetics
pregnane X receptor
Transcriptional Activation
Hepatocytes

Keywords

  • CYP3A4
  • Diindolylmethane
  • MDR1
  • PXR

ASJC Scopus subject areas

  • Toxicology
  • Medicine(all)

Cite this

Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR. / Pondugula, Satyanarayana R.; Flannery, Patrick C.; Abbott, Kodye L.; Coleman, Elaine S.; Mani, Sridhar; Samuel, Temesgen; Xie, Wen.

In: Toxicology Letters, Vol. 232, No. 3, 03.02.2015, p. 580-589.

Research output: Contribution to journalArticle

Pondugula, Satyanarayana R. ; Flannery, Patrick C. ; Abbott, Kodye L. ; Coleman, Elaine S. ; Mani, Sridhar ; Samuel, Temesgen ; Xie, Wen. / Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR. In: Toxicology Letters. 2015 ; Vol. 232, No. 3. pp. 580-589.
@article{270812530b78421dace9ef7f99bf391a,
title = "Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR",
abstract = "Activation of human pregnane X receptor (hPXR)-regulated expression of cytochrome P450 3A4 (CYP3A4) and multidrug resistance protein 1 (MDR1) plays an important role in mediating adverse drug interactions. Given the common use of natural products as part of adjunct human health behavior, there is a growing concern about natural products for their potential to induce undesired drug interactions through the activation of hPXR-regulated CYP3A4 and MDR1. Here, we studied whether 3,3'-diindolylmethane (DIM), a natural health supplement, could induce hPXR-mediated regulation of CYP3A4 and MDR1 in human hepatocytes and intestinal cells. DIM, at its physiologically relevant concentrations, not only induced hPXR transactivation of CYP3A4 promoter activity but also induced gene expression of CYP3A4 and MDR1. DIM decreased intracellular accumulation of MDR1 substrate rhodamine 123, suggesting that DIM induces the functional expression of MDR1. Pharmacologic inhibition or genetic knockdown of hPXR resulted in attenuation of DIM induced CYP3A4 and MDR1 gene expression, suggesting that DIM induces CYP3A4 and MDR1 in an hPXR-dependent manner. Together, these results support our conclusion that DIM induces hPXR-regulated CYP3A4 and MDR1 gene expression. The inductive effects of DIM on CYP3A4 and MDR1 expression caution the use of DIM in conjunction with other medications metabolized and transported via CYP3A4 and MDR1, respectively.",
keywords = "CYP3A4, Diindolylmethane, MDR1, PXR",
author = "Pondugula, {Satyanarayana R.} and Flannery, {Patrick C.} and Abbott, {Kodye L.} and Coleman, {Elaine S.} and Sridhar Mani and Temesgen Samuel and Wen Xie",
year = "2015",
month = "2",
day = "3",
doi = "10.1016/j.toxlet.2014.12.015",
language = "English (US)",
volume = "232",
pages = "580--589",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR

AU - Pondugula, Satyanarayana R.

AU - Flannery, Patrick C.

AU - Abbott, Kodye L.

AU - Coleman, Elaine S.

AU - Mani, Sridhar

AU - Samuel, Temesgen

AU - Xie, Wen

PY - 2015/2/3

Y1 - 2015/2/3

N2 - Activation of human pregnane X receptor (hPXR)-regulated expression of cytochrome P450 3A4 (CYP3A4) and multidrug resistance protein 1 (MDR1) plays an important role in mediating adverse drug interactions. Given the common use of natural products as part of adjunct human health behavior, there is a growing concern about natural products for their potential to induce undesired drug interactions through the activation of hPXR-regulated CYP3A4 and MDR1. Here, we studied whether 3,3'-diindolylmethane (DIM), a natural health supplement, could induce hPXR-mediated regulation of CYP3A4 and MDR1 in human hepatocytes and intestinal cells. DIM, at its physiologically relevant concentrations, not only induced hPXR transactivation of CYP3A4 promoter activity but also induced gene expression of CYP3A4 and MDR1. DIM decreased intracellular accumulation of MDR1 substrate rhodamine 123, suggesting that DIM induces the functional expression of MDR1. Pharmacologic inhibition or genetic knockdown of hPXR resulted in attenuation of DIM induced CYP3A4 and MDR1 gene expression, suggesting that DIM induces CYP3A4 and MDR1 in an hPXR-dependent manner. Together, these results support our conclusion that DIM induces hPXR-regulated CYP3A4 and MDR1 gene expression. The inductive effects of DIM on CYP3A4 and MDR1 expression caution the use of DIM in conjunction with other medications metabolized and transported via CYP3A4 and MDR1, respectively.

AB - Activation of human pregnane X receptor (hPXR)-regulated expression of cytochrome P450 3A4 (CYP3A4) and multidrug resistance protein 1 (MDR1) plays an important role in mediating adverse drug interactions. Given the common use of natural products as part of adjunct human health behavior, there is a growing concern about natural products for their potential to induce undesired drug interactions through the activation of hPXR-regulated CYP3A4 and MDR1. Here, we studied whether 3,3'-diindolylmethane (DIM), a natural health supplement, could induce hPXR-mediated regulation of CYP3A4 and MDR1 in human hepatocytes and intestinal cells. DIM, at its physiologically relevant concentrations, not only induced hPXR transactivation of CYP3A4 promoter activity but also induced gene expression of CYP3A4 and MDR1. DIM decreased intracellular accumulation of MDR1 substrate rhodamine 123, suggesting that DIM induces the functional expression of MDR1. Pharmacologic inhibition or genetic knockdown of hPXR resulted in attenuation of DIM induced CYP3A4 and MDR1 gene expression, suggesting that DIM induces CYP3A4 and MDR1 in an hPXR-dependent manner. Together, these results support our conclusion that DIM induces hPXR-regulated CYP3A4 and MDR1 gene expression. The inductive effects of DIM on CYP3A4 and MDR1 expression caution the use of DIM in conjunction with other medications metabolized and transported via CYP3A4 and MDR1, respectively.

KW - CYP3A4

KW - Diindolylmethane

KW - MDR1

KW - PXR

UR - http://www.scopus.com/inward/record.url?scp=84921739167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921739167&partnerID=8YFLogxK

U2 - 10.1016/j.toxlet.2014.12.015

DO - 10.1016/j.toxlet.2014.12.015

M3 - Article

VL - 232

SP - 580

EP - 589

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

IS - 3

ER -